S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
NASDAQ:WVE

Wave Life Sciences Stock Forecast, Price & News

$9.13
+0.16 (+1.78 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.82
Now: $9.13
$9.55
50-Day Range
$7.87
MA: $8.88
$10.35
52-Week Range
$6.61
Now: $9.13
$19.98
Volume471,317 shs
Average Volume781,772 shs
Market Capitalization$445.34 million
P/E RatioN/A
Dividend YieldN/A
Beta0.35
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Wave Life Sciences logo

MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

100th out of 1,556 stocks

Pharmaceutical Preparations Industry

45th out of 638 stocks

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:WVE
CUSIPN/A
Phone65-6236-3388
Employees301

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.98 million
Book Value$1.86 per share

Profitability

Net Income$-193,640,000.00
Net Margins-1,562.01%

Miscellaneous

Market Cap$445.34 million
Next Earnings Date3/1/2021 (Estimated)
OptionableOptionable
$9.13
+0.16 (+1.78 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

How has Wave Life Sciences' stock price been impacted by Coronavirus?

Wave Life Sciences' stock was trading at $8.12 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, WVE stock has increased by 12.4% and is now trading at $9.13.
View which stocks have been most impacted by COVID-19
.

Is Wave Life Sciences a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Wave Life Sciences stock.
View analyst ratings for Wave Life Sciences
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Wave Life Sciences?

Wall Street analysts have given Wave Life Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Wave Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Wave Life Sciences' next earnings date?

Wave Life Sciences is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for Wave Life Sciences
.

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd. (NASDAQ:WVE) posted its earnings results on Monday, November, 9th. The company reported ($0.86) EPS for the quarter, missing the Zacks' consensus estimate of ($0.73) by $0.13. The firm had revenue of $3.45 million for the quarter, compared to analyst estimates of $14.68 million. Wave Life Sciences had a negative net margin of 1,562.01% and a negative return on equity of 401.32%.
View Wave Life Sciences' earnings history
.

What price target have analysts set for WVE?

3 equities research analysts have issued 1-year price targets for Wave Life Sciences' stock. Their forecasts range from $13.00 to $27.00. On average, they expect Wave Life Sciences' share price to reach $19.75 in the next year. This suggests a possible upside of 116.3% from the stock's current price.
View analysts' price targets for Wave Life Sciences
or view Wall Street analyst' top-rated stocks.

Who are some of Wave Life Sciences' key competitors?

What other stocks do shareholders of Wave Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wave Life Sciences investors own include Gilead Sciences (GILD), Exelixis (EXEL), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), VBI Vaccines (VBIV), Aduro Biotech (ADRO), Cidara Therapeutics (CDTX), CRISPR Therapeutics (CRSP) and ImmunoGen (IMGN).

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the following people:
  • Dr. Paul B. Bolno M.B.A., M.D., MBA, Pres, CEO & Director (Age 47, Pay $881.53k)
  • Dr. Chandra Vargeese, Chief Technology Officer (Age 60, Pay $564.52k)
  • Dr. Michael A. Panzara M.P.H., M.D., MPH, Chief Medical Officer and Head of Therapeutics Discovery & Devel. (Age 54, Pay $597k)
  • Mr. Kyle B. Moran, CFO & Principal Accounting Officer (Age 50)
  • Kate Rausch, Head of Investor Relations
  • Ms. Linda Rockett J.D., Gen. Counsel
  • Dr. Christopher Francis Ph.D., Sr. VP of Corp. Devel. & Head of Emerging Areas (Age 43)
  • Mr. Jonathan Rosin, Chief HR Officer
  • Mr. Jose Juves, Sr. VP of Corp. Affairs & Patient Advocacy
  • Dr. Kenneth Rhodes, Sr. VP of Therapeutics Discovery

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

How do I buy shares of Wave Life Sciences?

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of WVE stock can currently be purchased for approximately $9.13.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $445.34 million and generates $15.98 million in revenue each year. The company earns $-193,640,000.00 in net income (profit) each year or ($5.72) on an earnings per share basis. Wave Life Sciences employs 301 workers across the globe.

What is Wave Life Sciences' official website?

The official website for Wave Life Sciences is www.wavelifesciences.com.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.